Publications by authors named "David J Gordon"

Claim this Profile
H
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells.
Stacia L Koppenhafer, Elizabeth L Geary, Mary V Thomas, Emma E Croushore, Jessica A O Zimmerman, David J Gordon

Cancer Res Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells.
Emma E Croushore, Christopher S Stipp, David J Gordon

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells.
Joseph A Haight, Stacia L Koppenhafer, Elizabeth L Geary, David J Gordon

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells.
Joseph A Haight, Stacia L Koppenhafer, Elizabeth L Geary, David J Gordon

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
Emma E Croushore, Stacia L Koppenhafer, Kelli L Goss, Elizabeth L Geary, David J Gordon

Cancer Res Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism.
Wade R Gutierrez, Amanda Scherer, Jeffrey D Rytlewski, Emily A Laverty, Alexa P Sheehan, David J Gordon

JCI Insight· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade.
Hanying Wang, Xin He, Lei Zhang, Haojie Dong, Feiteng Huang, David J Gordon

Blood· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symmetry of bilateral hallux valgus deformity: A radiographic study.
Sophie A Crooks, Thomas L Lewis, Robbie Ray, David J Gordon

Clin Anat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma.
Stacia L Koppenhafer, Kelli L Goss, Ellen Voigt, Emma Croushore, William W Terry, Peter M Gordon, David J Gordon

Oncogene· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo.
Jordan L Kohlmeyer, Courtney A Kaemmer, Joshua J Lingo, Ellen Voigt, Mariah R Leidinger, David J Gordon

Neurooncol Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy of prexasertib in acute lymphoblastic leukemia.
Jason Ostergaard, Leslie M Jonart, Maryam Ebadi, Stacia L Koppenhafer, David J Gordon, Peter M Gordon

Br J Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third-Generation Minimally Invasive Chevron and Akin Osteotomies (MICA) in Hallux Valgus Surgery: Two-Year Follow-up of 292 Cases.
Thomas L Lewis, Robbie Ray, George Miller, David J Gordon

J Bone Joint Surg Am· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors.
Kelli L Goss, Stacia L Koppenhafer, Torin Waters, William W Terry, Kuo-Kuang Wen, Peter M Gordon, David J Gordon

Oncogene· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapies for MPNSTs targeting RABL6A-RB1 signaling.
Jordan L Kohlmeyer, David J Gordon, Munir R Tanas, Rebecca D Dodd, Varun Monga

Oncotarget· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication.
Torin Waters, Kelli L Goss, Stacia L Koppenhafer, William W Terry, David J Gordon

BMC Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.
Jordan L Kohlmeyer, David J Gordon, Munir R Tanas, Varun Monga, Rebecca D Dodd

Int J Mol Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
Stacia L Koppenhafer, Kelli L Goss, William W Terry, David J Gordon

Mol Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Ascorbate Primes Pancreatic Cancer Cells for Death by Rewiring Cellular Energetics and Inducing DNA Damage.
Visarut Buranasudja, Claire M Doskey, Adrienne R Gibson, Brett A Wagner, Juan Du, David J Gordon

Mol Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells.
Stacia L Koppenhafer, Kelli L Goss, William W Terry, David J Gordon

Mol Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
Victoria L Pemberton, Frank Evans, Jamie Gulin, Ellen Rosenberg, Ebyan Addou, David J Gordon

Clin Trials· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy.
Jordan A Naumann, John C Widen, Leslie A Jonart, Maryam Ebadi, Jian Tang, David J Gordon, Peter M Gordon

Bioconjug Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.
Brandon R McNew, Benjamin W Darbro, Deqin Ma, David J Gordon

J Pediatr Hematol Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.
Kelli L Goss, Stacia L Koppenhafer, Kathryn M Harmoney, William W Terry, David J Gordon

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rejoinder.
Thomas R Fleming, David L DeMets, Matthew T Roe, Janet Wittes, Karim A Calis, David J Gordon

Clin Trials· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data monitoring committees: Promoting best practices to address emerging challenges.
Thomas R Fleming, David L DeMets, Matthew T Roe, Janet Wittes, Karim A Calis, David J Gordon

Clin Trials· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis